View our Privacy Policy & Terms of Use
This free content is available to registered users.
Becoming a Registered User only requires your name and email address.
Pretreatment Diabetes Has Lower Mortality Rate, Independent of Immune-Related Adverse Events, in Cancer Patients with Immune-Check Point Inhibitor
Speaker: Kaori Hisanaga
Session: New Insights into Immunomodulatory Therapies and Biomarkers of Autoimmune Disorder (With State-of-the-Art Lecture)
Congress: 79th Scientific Sessions